Ambulatory Blood Pressure Monitoring Devices Market Size & Growth Forecast 2027–2036, By Segments (End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Ambulatory Blood Pressure Monitoring Devices Market size was over USD 1.7 billion in 2026 and is likely to grow at a 11.02% CAGR between 2027 and 2036, reaching USD 4.84 billion by 2036. The industry revenue for 2027 is assessed at USD 1.86 billion.
Get more details on this report
Request Free Sample ReportAmbulatory Blood Pressure Monitoring Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 41.98% share, driven by routine hypertension screening, outpatient diagnostic integration, chronic disease management reliance, and mature device distribution supporting consistent ambulatory monitoring adoption.
- Asia Pacific is growing at 12.99% CAGR as healthcare infrastructure improves, access expands, and outpatient monitoring adoption increases across hospitals managing rising cardiovascular patient volumes.
Segment Momentum
- Hospitals accounted for 62.86% of the market in 2026 due to their central role in diagnosing complex hypertension cases and managing monitoring, interpretation, and follow-up within established clinical workflows.
- Homecare is growing fastest as patients increasingly prefer convenient monitoring outside healthcare facilities, supporting routine hypertension follow-up while reducing repeat visits and improving comfort during extended monitoring periods.
Market Expansion Drivers
- Rising global hypertension prevalence increasing demand for continuous blood pressure monitoring solutions.
- Expanding geriatric population accelerating adoption of ambulatory cardiovascular monitoring devices.
- Advancements in digital and mobile-connected ABPM devices improving remote patient monitoring capabilities.
Leading Market Participants
- Major companies in the ambulatory blood pressure monitoring devices market include Omron Corporation (Japan), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Spacelabs Healthcare, Inc. (United States), SunTech Medical, Inc. (United States), A&D Company, Limited (Japan), Microlife Corporation (Taiwan), Schiller AG (Switzerland), Hillrom Holdings, Inc. (United States), Withings (France).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.7 billion
- 2027 Estimated Market Size: USD 1.86 billion.
- Projected Market Size: USD 4.84 billion by 2036
- Growth Forecast: 11.02% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Ambulatory Blood Pressure Monitors (Product)
- Emerging Opportunity Segment: Homecare (End-use) | Ambulatory Blood Pressure Monitors (Product)
Market Growth Drivers and Industry Trends
Rising global hypertension prevalence increasing demand for continuous blood pressure monitoring solutions
The growing prevalence of hypertension will drive the ambulatory blood pressure monitoring devices market growth as healthcare providers increasingly require more comprehensive information about patients' blood pressure patterns beyond measurements collected during individual clinical visits. Ambulatory monitoring allows readings to be collected throughout normal daily activities and sleep, helping clinicians identify fluctuations and patterns that may not be apparent through occasional measurements. This continuous approach can support more informed assessment of blood pressure control and treatment management, particularly for patients requiring closer cardiovascular monitoring.
Expanding geriatric population accelerating adoption of ambulatory cardiovascular monitoring devices
An expanding older population is strengthening the ambulatory blood pressure monitoring devices market because aging is associated with greater demand for cardiovascular assessment and ongoing management of chronic conditions. Ambulatory devices allow older patients to undergo extended monitoring while continuing their routine activities, reducing reliance on repeated visits solely for blood pressure measurement. Healthcare providers can use the collected readings to evaluate variations over time and support individualized management strategies for patients requiring regular cardiovascular observation.
Advancements in digital and mobile-connected ABPM devices improving remote patient monitoring capabilities
Technological advances in digital and mobile-connected monitoring systems are creating new opportunities for the ambulatory blood pressure monitoring devices market by enabling more efficient collection, transmission, and interpretation of patient readings. Connected devices can transfer measurements to digital platforms, allowing healthcare professionals to review blood pressure information remotely and monitor changes between clinical appointments. Integration with mobile applications and remote care systems also supports more convenient patient participation while improving access to longitudinal monitoring data.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global hypertension prevalence increasing demand for continuous blood pressure monitoring solutions | 2.40% | High | North America, Asia Pacific, Africa | High | Near Term |
| Expanding geriatric population accelerating adoption of ambulatory cardiovascular monitoring devices | 2.10% | Moderate | Europe, North America, Asia Pacific | High | Mid Term |
| Advancements in digital and mobile-connected ABPM devices improving remote patient monitoring capabilities | 1.70% | Moderate | North America, Europe | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the ambulatory blood pressure monitoring devices market, North America held the largest share of 41.98% in 2026. The region benefits from advanced healthcare infrastructure, widespread adoption of diagnostic technologies, and growing emphasis on accurate hypertension assessment outside conventional clinical settings. Increasing awareness of cardiovascular risk management is supporting demand for continuous blood pressure monitoring, while established healthcare systems facilitate the integration of ambulatory monitoring into routine diagnostic and follow-up practices. Greater focus on preventive care and remote patient monitoring is also strengthening adoption across healthcare settings.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest growth in the ambulatory blood pressure monitoring devices market, driven by the rising burden of hypertension, expanding healthcare access, and increasing awareness of cardiovascular disease prevention. Improvements in diagnostic infrastructure and the gradual adoption of advanced monitoring technologies are enabling healthcare providers to identify and manage blood pressure abnormalities more effectively. Growing investment in healthcare modernization, coupled with demand for convenient and data-driven monitoring solutions, is creating favorable conditions for broader deployment throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Monitoring StandardsGermany prioritizes ambulatory blood pressure monitoring devices that support evidence-based cardiovascular care and standardized clinical workflows. Healthcare institutions in Germany continue integrating validated monitoring technologies with digital health systems to improve diagnostic efficiency and patient management.
France 🇫🇷
Preventive Cardiac CareFrance emphasizes ambulatory blood pressure monitoring as part of preventive cardiovascular care and routine hypertension assessment. Hospitals and outpatient clinics across France continue expanding the use of validated monitoring devices to enhance diagnosis and optimize treatment planning.
Italy 🇮🇹
Outpatient Diagnostic ExpansionItaly continues strengthening outpatient cardiovascular diagnostics through broader adoption of ambulatory blood pressure monitoring devices. Healthcare facilities in Italy increasingly value user-friendly systems that improve patient comfort while delivering accurate blood pressure measurements over extended monitoring periods.
Japan 🇯🇵
Aging Care SupportJapan increasingly deploys ambulatory blood pressure monitoring devices to support hypertension management among its aging population. Healthcare providers in Japan emphasize reliable long-duration monitoring solutions that enable early intervention and more personalized cardiovascular treatment decisions.
South Korea 🇰🇷
Digital Health AlignmentSouth Korea integrates ambulatory blood pressure monitoring devices with connected healthcare platforms and digital patient management initiatives. Medical providers in South Korea continue adopting compact monitoring systems that improve workflow efficiency and facilitate data-driven clinical decision-making.
United States 🇺🇸
Remote Care IntegrationThe U.S. ambulatory blood pressure monitoring devices market benefits from expanding remote patient monitoring programs and wider adoption of digital healthcare solutions. Healthcare providers across the U.S. increasingly incorporate ambulatory monitoring into hypertension management to improve diagnostic accuracy and long-term patient follow-up.
Segment Leadership and Growth Trends
Ambulatory Blood Pressure Monitoring Devices Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Homecare (Fastest-Growing Segment)
Hospitals segment accounted for the largest share of the ambulatory blood pressure monitoring devices market at 62.86% in 2026. Its leading position is supported by the extensive use of ambulatory monitoring in clinical settings for evaluating blood pressure patterns over extended periods and identifying variations that may not be captured through conventional measurements. Hospitals also benefit from access to specialized healthcare professionals who can interpret monitoring results and incorporate them into diagnosis and treatment decisions. Growing emphasis on accurate hypertension assessment and continuous patient monitoring further reinforces demand for these devices across hospital-based care.
Homecare is emerging as the fastest-growing end-use segment as healthcare delivery increasingly shifts toward convenient and patient-centered monitoring outside traditional clinical environments. Ambulatory blood pressure monitoring enables patients to collect measurements during normal daily activities, supporting more representative assessment while reducing the need for repeated facility visits. Rising interest in remote monitoring, greater patient participation in chronic disease management, and the broader adoption of home-based healthcare are creating favorable conditions for increased use of these devices in residential settings.
Product Segment Analysis: Ambulatory Blood Pressure Monitors (Largest & Fastest-Growing Segment)
Ambulatory blood pressure monitors represented both the largest and fastest-growing product segment, accounting for a 63.54% share of the ambulatory blood pressure monitoring devices market in 2026. Their strong position reflects the clinical value of capturing blood pressure readings over an extended period rather than relying solely on isolated measurements taken in healthcare settings. These devices support the identification of variations such as changes associated with daily activity and sleep, providing clinicians with a broader view of a patient's blood pressure profile. Increasing emphasis on accurate hypertension assessment and personalized monitoring is supporting their continued adoption across healthcare environments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Ambulatory Surgical Centers & Clinics, Homecare | Hospitals | Homecare |
| Product | Ambulatory Blood Pressure Monitors, Instrument & Accessories, Blood Pressure Cuffs, Others | Ambulatory Blood Pressure Monitors | Ambulatory Blood Pressure Monitors |
Competitive Landscape and Market Positioning
Top players in the ambulatory blood pressure monitoring devices market:
1. Omron Corporation (Japan)
2. Koninklijke Philips N.V. (Netherlands)
3. GE HealthCare Technologies Inc. (United States)
4. Spacelabs Healthcare Inc. (United States)
5. SunTech Medical Inc. (United States)
6. A&D Company Limited (Japan)
7. Microlife Corporation (Taiwan)
8. Schiller AG (Switzerland)
9. Hillrom Holdings Inc. (United States)
10. Withings (France)
The ambulatory blood pressure monitoring devices market is advancing through the development of more accurate, portable, and user-friendly monitoring systems designed to improve long-term cardiovascular assessment. Integration of digital health technologies and wireless connectivity features is enabling better remote monitoring and data accessibility for healthcare professionals. Growing emphasis on preventive healthcare and continuous patient monitoring is further supporting innovation across the ambulatory blood pressure monitoring devices market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Omron Corporation (Japan) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| GE HealthCare Technologies Inc. (United States) | |||||||
| Spacelabs Healthcare Inc. (United States) | |||||||
| SunTech Medical Inc. (United States) | |||||||
| A&D Company Limited (Japan) | |||||||
| Microlife Corporation (Taiwan) | |||||||
| Schiller AG (Switzerland) | |||||||
| Hillrom Holdings Inc. (United States) | |||||||
| Withings (France). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Sky Labs | May-26 | The "CART BP pro" ring-type cuffless blood pressure monitor became the world’s first of its kind to be integrated into the 2026 Korean Society of Hypertension Guidelines. By utilizing AI-powered photoplethysmography, the device allows for 24-hour monitoring without the discomfort of inflatable cuffs, providing a clinically validated alternative for tracking nocturnal and resistant hypertension. |
| OMRON Healthcare | Dec-25 | OMRON Healthcare unveiled a global ECG strategy aimed at integrating home-based cardiovascular monitoring with hospital care. This initiative includes expanding the "KeeboHealth" platform—which links ECG-enabled blood pressure monitors with AI-based interpretation services—to provide continuous, data-driven management for patients at risk of heart failure. |
| Aktiia SA | Jul-25 | Aktiia received FDA clearance for its "Hilo Band," marking the first time a cuffless blood pressure monitor has been approved for over-the-counter use in the United States. The wrist-worn device utilizes light-based sensors to provide 24-hour automated monitoring, significantly improving patient compliance and comfort compared to traditional, inflatable cuff-based ambulatory systems. |
| ASUSTeK Computer | Apr-25 | ASUSTeK launched the "VivoWatch 6 AERO" smart band, integrating cuffless blood pressure and ECG measurement via advanced fingertip sensors. This development highlights the market trend of incorporating medical-grade diagnostic capabilities into consumer-friendly, lightweight wearable technology for real-time health tracking and AI-driven insights. |
| Myant Inc. | Jan-25 | Myant Inc. acquired mmHg Inc. to bolster its remote care portfolio. By integrating mmHg’s cardiovascular monitoring platform into its existing AI-enabled solutions, Myant aims to enhance the delivery of personalized, medical-grade remote health monitoring for chronic condition management, including hypertension detection and long-term blood pressure tracking. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Ambulatory Blood Pressure Monitoring Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Measurement Technology | Oscillometric, Auscultatory, Hybrid |
| Connectivity | Bluetooth-Enabled, Cellular-Connected, USB/PC-Connected, Standalone |
| Monitoring Duration | 24-Hour Monitoring, 48-Hour Monitoring, Extended Monitoring |
Ambulatory Blood Pressure Monitoring Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Out-of-Hospital Hypertension Care Pathway Analysis |
|
| Healthcare Reimbursement and Market Access Assessment |
|
| Remote Patient Monitoring Ecosystem Evaluation |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the ambulatory blood pressure monitoring devices market?
How much is the ambulatory blood pressure monitoring devices industry expected to grow by 2036?
How is rising hypertension prevalence influencing procurement strategies in the ambulatory blood pressure monitoring devices market?
Why are connected ABPM devices becoming a strategic investment priority for healthcare providers?
Why do hospitals lead the ambulatory blood pressure monitoring devices market?
Why is homecare becoming the fastest-growing end-use segment in the ambulatory blood pressure monitoring devices market?
Why does North America lead the ambulatory blood pressure monitoring devices market?
How is Asia Pacific driving growth in this market?
Which companies are driving growth in the ambulatory blood pressure monitoring devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization